Form 4: Albert Friedberg and FCMI Parent Co. Report Beneficial Ownership Changes in VaccinEx, Inc. (VCNX)
SEC Form 4 Filing
Albert Friedberg, a director and 10% owner of VaccinEx, Inc., along with FCMI Parent Co., reported changes in beneficial ownership of the company's common stock and warrants.
Summary
- On August 5th and 6th, 2024, Albert Friedberg and FCMI Parent Co. engaged in transactions involving VaccinEx, Inc. (VCNX) common stock.
- These transactions involved the purchase of 3,653 shares on August 5th at $4.6 per share and 2,753 shares on August 6th at $4.92 per share by FCMI Parent Co.
- Following these transactions, FCMI Parent Co. beneficially owns 780,524 shares of common stock.
- Albert Friedberg also indirectly owns shares through Pan Atlantic Holdings Ltd. (180 shares) and Friedberg Global-Macro Hedge Fund Ltd. (16,724 shares).
- FCMI Parent Co. also indirectly owns warrants to purchase 102,960, 118,226, and 214,285 shares of common stock at exercise prices of $7.64, $14, and $14 respectively.
- Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports transactions without expressing a strong positive or negative outlook. The purchases could be seen as slightly positive, but the disclaimers of beneficial ownership temper this.
Positives
- The purchases by FCMI Parent Co. indicate a potential positive outlook on VaccinEx, Inc.
Management Comments
- Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Industry Context
This filing is a routine disclosure of changes in beneficial ownership, which is common for directors and significant shareholders of publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for insiders of publicly traded companies, as mandated by the SEC.
- The transactions are relatively small in scale compared to overall market capitalization, but are still relevant due to the insider status of the reporting persons.
Stakeholder Impact
- The transactions may have a minor positive impact on shareholder confidence due to insider buying.
Key Dates
| Date | Description |
|---|---|
| 10/03/2023 | Date of warrant expiration for 214,285 shares at $14 |
| 02/08/2024 | Date of warrant expiration for 118,226 shares at $14 |
| 03/28/2024 | Date of warrant expiration for 102,960 shares at $7.64 |
| 08/05/2024 | FCMI Parent Co. purchased 3,653 shares at $4.6 per share. |
| 08/06/2024 | FCMI Parent Co. purchased 2,753 shares at $4.92 per share. |
| 08/07/2024 | Date of filing. |
| 10/03/2028 | Expiration date of warrant for 214,285 shares at $14 |
| 02/08/2029 | Expiration date of warrant for 118,226 shares at $14 |
| 03/28/2029 | Expiration date of warrant for 102,960 shares at $7.64 |
Keywords
VaccinEx, VCNX, beneficial ownership, Form 4, Albert Friedberg, FCMI Parent Co., common stock, warrants, securities, transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.